Terumo BCT is a global leader in blood component, therapeutic apheresis and cell therapy technologies. We believe in the potential of blood and cells to do even more for patients than they do today. Terumo BCT’s Cell Therapy Technologies business enables researchers, developers and manufacturers to create next-generation cell and gene therapies. We do this through flexible, automated solutions that help meet evolving needs for reproducibility, quality and scale through the phases of development, from translational research to current good manufacturing practices (cGMP) for commercial manufacturing.Terumo BCT
10810 W. Collins Avenue
Lakewood, CO 80215-4440
+1 303 205 2599
2 Oct 2019
Terumo BCT’s latest cell therapy technology, the Finia Fill and Finish System, is a first-of-its-kind device developed to help bring reproducibility and control to cell therapy manufacturing to get therapies to more patients who need them.
23 Sep 2019
Terumo BCT’s new USD $100,000 Therapeutic Plasma Exchange (TPE) Innovation Award will help clinical investigators expand the field of data for certain types of autoimmune conditions, known as IgG4-mediated diseases.